M79.10 classifies muscle pain (myalgia) at an anatomically unspecified site — use it only when the clinical documentation genuinely does not identify which muscle group or body region is affected.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 8
- Region
- General
Documentation tips
What should appear in the chart to support M79.10.
Source · Editorial brief grounded in 5 cited references ↓
- Document why the site is unspecified — e.g., diffuse, migratory, or patient unable to localize — to justify M79.10 over a site-specific code.
- If the provider names any body region (e.g., 'shoulder girdle muscle pain,' 'cervical muscle aching'), query for M79.12 or M79.18 rather than defaulting to M79.10.
- Explicitly note the absence of fibromyalgia, myositis, or psychogenic etiology in the assessment to support M79.10 and satisfy the Excludes1 requirements at M79.1 and M79.
- Record functional impact — interference with ADLs, work, or exercise — to establish medical necessity for associated therapeutic CPT codes.
- For trigger-point injection claims (20552, 20553), document the specific muscle(s) injected; a site-unspecified diagnosis code paired with a site-specific procedure will attract scrutiny.
Related CPT procedures
Procedure codes commonly billed with M79.10. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M79.10 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M79.10 when the note documents a named muscle group or body region — that defaults you to M79.11, M79.12, or M79.18 and better satisfies specificity requirements.
- Assigning M79.10 for fibromyalgia — M79.7 is required; fibromyalgia is Excludes1 at M79.1, making M79.10 an invalid choice.
- Confusing myalgia with myositis (M60.-): if inflammation is documented or suspected, M79.10 is excluded and M60.- applies.
- Placing M79.10 as the primary diagnosis on a limb-pain encounter instead of the appropriate M79.6x code when the pain is localized to an extremity.
- Routine use of M79.10 across a patient panel without revisiting specificity — payer algorithms flag high-frequency unspecified coding as an audit indicator.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M79.10 is the fallback code within the M79.1 myalgia family when site cannot be determined from the documentation. The parent category M79.1 expanded in FY2019 to include site-specific child codes: M79.11 (mastication muscles), M79.12 (auxiliary muscles of head and neck), and M79.18 (other site). M79.10 exists for the residual cases where no site is captured — not as a convenience code when the provider simply didn't specify.
Before assigning M79.10, rule out codes that supersede it. Fibromyalgia maps to M79.7 (Excludes1 at M79.1). Myositis maps to M60.- (Excludes1 at M79.1). Psychogenic muscle pain maps to F45.41 or F45.8 (Excludes1 at M79). Pain localized to a limb, hand, foot, fingers, or toes belongs in M79.6x, not M79.10. If the provider's note names a region — even broadly — query for a more specific code before defaulting to unspecified.
In an orthopedic context, M79.10 appears most often as a secondary or working diagnosis during early evaluation visits when workup is ongoing. It is valid for billing but carries audit exposure if used habitually when specificity is available. Payers may flag or downcode claims where M79.10 is the sole diagnosis on a procedure claim without supporting documentation of why the site is unknown.
Sibling codes
Other billable codes under M79.1 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01When is M79.10 the correct code versus M79.18?
02Can M79.10 and M79.7 (fibromyalgia) be coded together?
03Is M79.10 valid as a primary diagnosis on a trigger-point injection claim?
04Does M79.10 require a 7th-character extension?
05How does M79.10 differ from R52 (Pain, unspecified)?
06Will payers deny M79.10 outright?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M70-M79/M79-/M79.10
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M79.10
- 04aapc.comhttps://www.aapc.com/codes/coding-newsletters/my-orthopedic-coding-alert/icd-10-cm-update-code-set-for-2019-includes-expanded-myalgia-options-158113-article
- 05icdcodes.aihttps://icdcodes.ai/diagnosis/myalgia/documentation
Mira AI Scribe
Mira captures whether the patient localizes muscle pain to a specific region or describes it as diffuse and non-localizable, flags any prior fibromyalgia or myositis diagnosis, and notes functional limitations documented in the encounter. This prevents unwarranted use of the unspecified code M79.10 when site-specific documentation supports M79.11, M79.12, or M79.18, and avoids audit exposure from habitual unspecified coding.
See how Mira captures M79.10 documentation